Navidea Biopharmaceuticals - 33 Year Stock Price History | NAVB
- The all-time high Navidea Biopharmaceuticals stock closing price was 440.00 on March 22, 1996.
- The Navidea Biopharmaceuticals 52-week high stock price is 0.13, which is % above the current share price.
- The Navidea Biopharmaceuticals 52-week low stock price is 0.00, which is % below the current share price.
- The average Navidea Biopharmaceuticals stock price for the last 52 weeks is 0.00.
Navidea Biopharmaceuticals Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 0.0007 | 0.0001 | 0.0100 | 0.0001 | 0.0002 | 100.00% |
2024 | 0.0170 | 0.0540 | 0.0642 | 0.0001 | 0.0001 | -99.82% |
2023 | 0.1495 | 0.2700 | 0.3428 | 0.0300 | 0.0552 | -73.71% |
2022 | 0.6179 | 1.2000 | 1.2000 | 0.1770 | 0.2100 | -79.00% |
2021 | 1.7931 | 2.2700 | 2.9000 | 1.0000 | 1.0000 | -53.49% |
2020 | 2.2506 | 1.2900 | 4.9500 | 0.7000 | 2.1500 | 70.63% |
2019 | 1.5742 | 2.2931 | 3.6000 | 0.5000 | 1.2600 | -38.63% |
2018 | 5.1365 | 7.7800 | 8.1980 | 2.0531 | 2.0531 | -71.37% |
2017 | 9.5384 | 12.9260 | 15.4620 | 6.8740 | 7.1700 | -43.76% |
2016 | 16.8253 | 25.8000 | 30.0000 | 6.0000 | 12.7500 | -52.07% |
2015 | 33.8508 | 38.6000 | 48.2000 | 24.8000 | 26.6000 | -29.63% |
2014 | 30.9714 | 40.0000 | 41.2000 | 20.4000 | 37.8000 | -8.70% |
2013 | 51.8183 | 57.6000 | 68.2000 | 28.0000 | 41.4000 | -26.86% |
2012 | 62.1328 | 54.8000 | 93.6000 | 43.8000 | 56.6000 | 8.02% |
2011 | 65.4746 | 42.4000 | 109.6000 | 39.0000 | 52.4000 | 27.18% |
2010 | 36.5064 | 23.4000 | 43.4000 | 23.4000 | 41.2000 | 68.85% |
2009 | 18.5474 | 11.2200 | 28.0000 | 9.0000 | 24.4000 | 114.04% |
2008 | 10.6386 | 6.4000 | 16.8000 | 6.4000 | 11.4000 | 99.30% |
2007 | 5.3338 | 5.0000 | 9.8000 | 3.8000 | 5.7200 | 19.17% |
2006 | 5.5200 | 5.0000 | 7.2000 | 4.6000 | 4.8000 | -2.04% |
2005 | 7.5109 | 12.0000 | 13.8000 | 4.9000 | 4.9000 | -58.12% |
2004 | 10.2239 | 6.4000 | 20.0000 | 5.8000 | 11.7000 | 88.71% |
2003 | 4.0536 | 2.6000 | 9.5000 | 2.0000 | 6.2000 | 138.46% |
2002 | 5.2543 | 8.4000 | 10.0000 | 1.5000 | 2.6000 | -69.05% |
2001 | 10.2732 | 8.1250 | 18.4000 | 7.0000 | 8.4000 | 0.00% |
2000 | 17.5448 | 9.0000 | 60.0000 | 7.5000 | 8.4000 | -4.00% |
1999 | 14.4324 | 17.5000 | 36.2500 | 6.2000 | 8.7500 | -39.13% |
1998 | 59.1220 | 127.5000 | 127.5000 | 10.0000 | 14.3750 | -88.02% |
1997 | 261.0524 | 302.5000 | 357.5000 | 120.0000 | 120.0000 | -60.98% |
1996 | 327.7153 | 315.0000 | 440.0000 | 215.0000 | 307.5000 | -4.65% |
1995 | 164.8239 | 30.0000 | 360.0000 | 30.0000 | 322.5000 | 975.00% |
1994 | 88.5800 | 123.7500 | 145.0000 | 23.7500 | 30.0000 | -76.00% |
1993 | 121.7959 | 122.5000 | 155.0000 | 105.0000 | 125.0000 | 4.17% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $195.148B | 85.47 |
Thermo Fisher Scientific (TMO) | United States | $162.069B | 19.60 |
Edwards Lifesciences (EW) | United States | $45.045B | 29.53 |
IDEXX Laboratories (IDXX) | United States | $43.992B | 50.56 |
Alcon (ALC) | Switzerland | $43.297B | 29.26 |
DexCom (DXCM) | United States | $32.517B | 50.26 |
IQVIA Holdings (IQV) | United States | $28.414B | 15.91 |
Mettler-Toledo (MTD) | United States | $25.128B | 29.88 |
STERIS (STE) | Ireland | $23.368B | 25.74 |
Waters (WAT) | United States | $20.841B | 29.41 |
SONOVA HOLDING (SONVY) | Switzerland | $17.678B | 0.00 |
Hologic (HOLX) | United States | $14.436B | 15.69 |
Sysmex ADR (SSMXY) | Japan | $10.859B | 30.80 |
Penumbra (PEN) | United States | $9.723B | 76.31 |
Masimo (MASI) | United States | $9.086B | 33.51 |
Globus Medical (GMED) | United States | $8.010B | 19.09 |
Glaukos (GKOS) | United States | $5.914B | 0.00 |
Teleflex (TFX) | United States | $5.298B | 8.75 |
TransMedics (TMDX) | United States | $4.370B | 94.99 |
Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
PROCEPT BioRobotics (PRCT) | United States | $3.205B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.515B | 14.98 |
Nihon Kohden (NHNKY) | Japan | $2.346B | 26.90 |
Veracyte (VCYT) | United States | $2.154B | 30.23 |
Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
Artivion (AORT) | United States | $1.312B | 122.88 |
Tandem Diabetes Care (TNDM) | United States | $1.118B | 0.00 |
OPKO Health (OPK) | United States | $1.079B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.048B | 5.57 |
Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
SiBone (SIBN) | United States | $0.787B | 0.00 |
IRadimed (IRMD) | United States | $0.786B | 39.87 |
Beta Bionics (BBNX) | United States | $0.586B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.571B | 8.88 |
Mesa Laboratories (MLAB) | United States | $0.564B | 13.22 |
OrthoPediatrics (KIDS) | United States | $0.546B | 0.00 |
RxSight (RXST) | United States | $0.530B | 0.00 |
AxoGen (AXGN) | United States | $0.498B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.480B | 0.00 |
Semler Scientific (SMLR) | United States | $0.451B | 12.00 |
Delcath Systems (DCTH) | United States | $0.442B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.436B | 0.00 |
AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.389B | 0.00 |
NeuroPace (NPCE) | United States | $0.341B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.327B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.284B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
908 Devices (MASS) | United States | $0.238B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
Neuronetics (STIM) | United States | $0.224B | 0.00 |
Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
Inogen (INGN) | United States | $0.201B | 0.00 |
CVRx (CVRX) | United States | $0.172B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.159B | 0.00 |
LENSAR (LNSR) | United States | $0.155B | 0.00 |
Accuray (ARAY) | United States | $0.146B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
InspireMD (NSPR) | United States | $0.069B | 0.00 |
Spectral AI (MDAI) | United States | $0.068B | 0.00 |
Hyperfine (HYPR) | United States | $0.062B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Envoy Medical (COCH) | United States | $0.033B | 0.00 |
DarioHealth (DRIO) | United States | $0.031B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
NexGel (NXGL) | United States | $0.020B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
PAVmed (PAVM) | United States | $0.010B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.07 |